EDHECinfra Post
Did Alteria overpay for the Chicago Skyway?
Publication date: 2022-09-22

On September 14, Atlas Arteria announced it acquired a 67% majority stake in the Chicago Skyway Toll Bridge for US$2 billion. This was in sharp opposition to the views of IFM, one of its shareholders, which claimed it was “value destructive”. Yesterday IFM got specific, accusing Atlas Alteria of destroying AUD$1 billion of value through the acquisition.

The Skyway deal is priced way higher than the mean, but is not the most expensive toll road out there. True, the deal represents an EV/EBITDA ratio of more than 43x, which is lofty on an absolute basis. But it looks a lot less crazy when compared to the average EV/EBIDTA ratio over the past 6 quarters for global merchant roads, data which can be found in infraMetrics’s Asset Valuation app.

Crucially, Skyway has an 81-year remaining concession life, while the current average in the infraMetrics database is 26 years. Looking at EV/EBITDA vs. remaining concession life reveals the following: merchant road concessions that have a remaining life of 75 years or more have average EV/EBITDA ratios around 45x, that is about three times higher than the average.

So, was Skyway really overpriced? If you add the high growth expectations of the buyer for the forward cycle, it may not be so silly.

Author(s):

  • Michelle Ho, Director of Investor Outreach, EDHECinfra
Did Alteria overpay for the Chicago Skyway?
infraMetrics™ by EDHECinfra

DISCLAIMER

  • The information contained on the EDHECinfra website (the “information”) has been prepared by EDHECinfra® solely for informational purposes, is not a recommendation to participate in any particular investment strategy and should not be considered as an investment advice or an offer to sell or buy certain securities.

    The rest of this disclaimer can be read on the legal page of this website.

    The terms contained in this Disclaimer are in addition to the Terms of Service for users without a subscription applicable to the EDHECinfra® website, which are incorporated herein by reference.

    This site uses cookies to deliver the services you request, improve user experience and measure audience. By continuing to browse our website, you are consenting to our use of cookies. Find out more about this in our Privacy policy.

    By clicking ‘yes’ below you agree to the terms of service

  • X
    X
    X